LATEST

• REGULATORY Japan Has Limited Drug Pricing Cards to Play on MFN, Should Expand CEA: MOF Official
  October 5, 2026

• BUSINESS Daiichi-AZ, Summit Team Up on Datroway Combo in Multiple Cancers
  October 5, 2026

• BUSINESS Taiho, Cullinan Start US Filing for Zipalertinib-Chemo Combo
  October 5, 2026

• BUSINESS Stargardt Diagnosis System Needs Bolstering as Treatment Nears: Expert
  October 5, 2026

• REGULATORY RMPs to Become Statutory Requirement under PMD Act in May 2027
  October 5, 2026

• REGULATORY Japan Panel Calls for Better Infrastructure to Expand RLT Access
  October 5, 2026

• REGULATORY Drug Discovery Fund Cleared to Provide Funding to Startups
  October 5, 2026

• BUSINESS AstraZeneca Opens Japan Recruitment for Young Oncologist Program
  October 5, 2026

• BUSINESS Cheplapharm to Acquire MA for Kyowa Kirin’s 5-FU Products
  October 5, 2026

• REGULATORY MHLW Simplifies Repatha Optimal Use Guidelines
  October 5, 2026

• BUSINESS Nippon Kayaku Completes Buyout of Fuji’s Toyama Plant
  October 5, 2026

• BUSINESS Teijin Finds “Best Owners” for Mucosolvan, Laxoberon
  October 5, 2026

• BUSINESS Maruho Expands Rapifort Deal with Orient EuroPharma to ASEAN
  October 5, 2026

• BUSINESS CellFiber Opens US Base to Drive Adoption of Cell Culture Technology
  October 5, 2026

• BUSINESS JCR Licenses Izcargo Rights to Italfarmaco in US, Europe, Latin America
  October 5, 2026

• REGULATORY No Financial Aid Planned for OTC-Like Drug Charge System Changes: Ueno
  October 5, 2026

• REGULATORY Leustatin Label to Warn Against Breastfeeding for 7 Days after Treatment
  October 5, 2026

• BUSINESS Gilead Paints Sustained Growth Curve with Trodelvy, CAR-T Therapies
  October 2, 2026

• REGULATORY US Narrows Scope of Medicare MFN Model, Exempts Orphan-Only Drugs
  October 2, 2026

• BUSINESS CSL Behring Japan Names Edward Wright as New Chief
  October 2, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• …
• Next ›
• 最終 »